Abstract
Acute pancreatitis is the most common serious complication of endoscopic retrograde cholangiopancreatography (ERCP) resulting in significant morbidity and occasional mortality. Post-ERCP pancreatitis (PEP) has been recognized since ERCP was first performed, and many studies have shown a consistent risk that must be balanced against the many benefits of this procedure. This review will discuss the pathogenesis, epidemiology, potential risk factors, and clinical presentation of PEP. Moreover, it will discuss in detail the most recent updates of PEP prevention and management.
Cite
CITATION STYLE
Obeidat, A. E., Mahfouz, R., Monti, G., Kozai, L., Darweesh, M., Mansour, M. M., … Hernandez, D. (2022). Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: What We Already Know. Cureus. https://doi.org/10.7759/cureus.21773
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.